abstract |
The invention is concerned with novel heteroaryl fused cyclic amines of formula (I) n n nwherein A, X 1 to X 3 , Y 1 to Y 3 , Z, R 1 , R 2 , m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit coagulation factor Xa and can be used as medicaments. |